Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
🕑 1 min read
Markers released top-line results today after previously reporting the trial succeeded.
Source: Ars Technica – All content — Read the original story
Breaking News, Politics, Business & Culture Across America
Breaking News, Politics, Business & Culture Across America